biomarker_id biomarker assessed_biomarker_entity assessed_biomarker_entity_id assessed_entity_type condition condition_id exposure_agent exposure_agent_id best_biomarker_role specimen specimen_id loinc_code evidence_source evidence tag vocab_pattern biomarker_controlled_vocab component_group flags BB1476-1 increased level of ITIH4 derived peptides Inter-alpha-trypsin inhibitor heavy chain H4 UPKB:Q14624 protein breast cancer DOID:1612 risk blood UBERON:0000178 UPKB:Q14624 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein ITIH4/UPKB:Q14624 203440 BB1476-1 increased level of ITIH4 derived peptides Inter-alpha-trypsin inhibitor heavy chain H4 UPKB:Q14624 protein breast cancer DOID:1612 risk blood UBERON:0000178 PubMed:21137033 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein ITIH4/UPKB:Q14624 203440 BB1477-1 increased level of ITIH4 derived peptides Inter-alpha-trypsin inhibitor heavy chain H4 PRO:0000016542 protein cerebrovascular disease DOID:6713 risk blood UBERON:0000178 UPKB:Q14624 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein inter-alpha-trypsin inhibitor heavy chain H4/PRO:0000016542 203441 BB1477-1 increased level of ITIH4 derived peptides Inter-alpha-trypsin inhibitor heavy chain H4 PRO:0000016542 protein cerebrovascular disease DOID:6713 risk blood UBERON:0000178 PubMed:19263524 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein inter-alpha-trypsin inhibitor heavy chain H4/PRO:0000016542 203441 BB1478-1 increased levels of LAMP5 Lysosome-associated membrane glycoprotein 5 UPKB:Q9UJQ1 protein blastic plasmacytoid dendritic cell neoplasm DOID:0081076 risk blood UBERON:0000178 UPKB:Q9UJQ1 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein LAMP5/UPKB:Q9UJQ1 203442 BB1478-1 increased levels of LAMP5 Lysosome-associated membrane glycoprotein 5 UPKB:Q9UJQ1 protein blastic plasmacytoid dendritic cell neoplasm DOID:0081076 risk blood UBERON:0000178 PubMed:21642595 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein LAMP5/UPKB:Q9UJQ1 203442 BB1479-1 decreased levels of UBX2A UBX domain-containing protein 2A UPKB:P68543 protein colorectal cancer DOID:9256 risk blood UBERON:0000178 UPKB:P68543 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:decreased;aspect_type:level Decreased level of protein UBXN2A/UPKB:P68543 203443 BB1479-1 decreased levels of UBX2A UBX domain-containing protein 2A UPKB:P68543 protein colorectal cancer DOID:9256 risk blood UBERON:0000178 PubMed:37037900 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:decreased;aspect_type:level Decreased level of protein UBXN2A/UPKB:P68543 203443 BB1480-1 decreased levels of MYBPHL Myosin-binding protein H-like UPKB:A2RUH7 protein cardiovascular system disease DOID:1287 risk blood UBERON:0000178 UPKB:A2RUH7 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:decreased;aspect_type:level Decreased level of protein MYBPHL/UPKB:A2RUH7 203444 BB1480-1 decreased levels of MYBPHL Myosin-binding protein H-like UPKB:A2RUH7 protein cardiovascular system disease DOID:1287 risk blood UBERON:0000178 PubMed:28778945 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:decreased;aspect_type:level Decreased level of protein MYBPHL/UPKB:A2RUH7 203444 BB1481-1 increased levels of METTL13 eEF1A lysine and N-terminal methyltransferase UPKB:Q8N6R0 protein ovarian cancer DOID:2394 risk blood UBERON:0000178 UPKB:Q8N6R0 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein METTL13/UPKB:Q8N6R0 203445 BB1481-1 increased levels of METTL13 eEF1A lysine and N-terminal methyltransferase UPKB:Q8N6R0 protein ovarian cancer DOID:2394 risk blood UBERON:0000178 PubMed:27659353 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein METTL13/UPKB:Q8N6R0 203445 BB1481-2 increased levels of METTL13 eEF1A lysine and N-terminal methyltransferase UPKB:Q8N6R0 protein lung non-small cell carcinoma DOID:3908 risk blood UBERON:0000178 UPKB:Q8N6R0 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein METTL13/UPKB:Q8N6R0 203446 BB1481-2 increased levels of METTL13 eEF1A lysine and N-terminal methyltransferase UPKB:Q8N6R0 protein lung non-small cell carcinoma DOID:3908 risk blood UBERON:0000178 PubMed:27659353 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein METTL13/UPKB:Q8N6R0 203446 BD0290-1 increased levels of HDAC10 Polyamine deacetylase HDAC10 UPKB:Q969S8 protein doxorubicin PCCID:31703 predictive tissue UBERON:0000479 UPKB:Q969S8 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein HDAC10/UPKB:Q969S8 203447 BD0290-1 increased levels of HDAC10 Polyamine deacetylase HDAC10 UPKB:Q969S8 protein doxorubicin PCCID:31703 predictive tissue UBERON:0000479 PubMed:23801752 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein HDAC10/UPKB:Q969S8 203447 BB1483-1 increased levels of VLP-1 Visinin-like protein 1 UPKB:P62760 protein Alzheimer's disease DOID:10652 risk cerebrospinal fluid UBERON:0001359 UPKB:P62760 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein VSNL1/UPKB:P62760 203448 BB1484-1 increased levels of SAPDC2 Suppressor APC domain-containing protein 2 UPKB:Q86UD0 protein colorectal cancer DOID:9256 prognostic blood UBERON:0000178 UPKB:Q86UD0 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein SAPCD2/UPKB:Q86UD0 203449 BB1485-1 underexpression of KLK10 KLK10 NCBI:5655 gene breast cancer DOID:1612 risk blood UBERON:0000178 UPKB:O43240 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:decreased;aspect_type:expression Decreased expression of gene KLK10/NCBI:5655 203450 BB1486-1 differential expression of TNMD Rad50 NCBI:64012 gene obesity DOID:9970 risk blood UBERON:0000178 UPKB:Q9H2S6 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:differential;aspect_type:expression Differential expression of gene Rad50/NCBI:64012 203451 BB1486-2 differential expression of TNMD Rad50 NCBI:64012 gene Alzheimer's disease DOID:10652 risk blood UBERON:0000178 UPKB:Q9H2S6 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:differential;aspect_type:expression Differential expression of gene Rad50/NCBI:64012 203452 BB1487-1 presence of L-homoarginine Homoarginine PCCID:9085 metabolite cardiovascular system disease DOID:1287 prognostic blood UBERON:0000178 UPKB:P52569 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:presence of;aspect_type:level Presence of level of metabolite homoarginine/PCCID:9085 203453 BB1488-1 decreased expression of HGAL GCSAM NCBI:257144 gene lymphoma DOID:0060058 risk blood UBERON:0000178 UPKB:Q9UKX2 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:decreased;aspect_type:expression Decreased expression of gene GCSAM/NCBI:257144 203454 BB1488-1 decreased expression of HGAL GCSAM NCBI:257144 gene lymphoma DOID:0060058 risk blood UBERON:0000178 PubMed:17823310 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:decreased;aspect_type:expression Decreased expression of gene GCSAM/NCBI:257144 203454 BB1489-1 increased expression of MIEN1 MIEN1 NCBI:84299 gene breast cancer DOID:1612 risk blood UBERON:0000178 UPKB:Q9BRT3 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:expression Increased expression of gene MIEN1/NCBI:84299 203455 BB1489-1 increased expression of MIEN1 MIEN1 NCBI:84299 gene breast cancer DOID:1612 risk blood UBERON:0000178 PubMed:17121940 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:expression Increased expression of gene MIEN1/NCBI:84299 203455 BB1490-1 DEFB126 mutation DEFB126 NCBI:81623 gene oligoasthenoteratozoospermia DOID:0070311 risk blood UBERON:0000178 UPKB:Q9BYW3 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:presence of;mod_type:sequence variation Presence of bmkb_II::mutation sequence variation in gene DEFB126/NCBI:81623 203456 check_entity BB1490-1 DEFB126 mutation DEFB126 NCBI:81623 gene oligoasthenoteratozoospermia DOID:0070311 risk blood UBERON:0000178 PubMed: 26832966 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:presence of;mod_type:sequence variation Presence of bmkb_II::mutation sequence variation in gene DEFB126/NCBI:81623 203456 check_entity BB1491-1 decreased expression of SLC46A3 SLC46A3 NCBI:283537 gene antibody drug conjugates NCIt:C1512 predictive blood UBERON:0000178 UPKB:Q7Z3Q1 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:decreased;aspect_type:expression Decreased expression of gene SLC46A3/NCBI:283537 203457 BB1491-1 decreased expression of SLC46A3 SLC46A3 NCBI:283537 gene antibody drug conjugates NCIt:C1512 predictive blood UBERON:0000178 PubMed:30131388 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:decreased;aspect_type:expression Decreased expression of gene SLC46A3/NCBI:283537 203457 BB1492-1 WFDC2 amplification WFDC2 NCBI:10406 gene ovarian cancer DOID:2394 risk blood UBERON:0000178 UPKB:Q14508 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of gene WFDC2/NCBI:10406 203458 BB1492-1 WFDC2 amplification WFDC2 NCBI:10406 gene ovarian cancer DOID:2394 risk blood UBERON:0000178 PubMed:12839961 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of gene WFDC2/NCBI:10406 203458 BB1493-1 decreased levels of BLCAP Apoptosis inducing factor BLCAP UPKB:P62952 protein urinary bladder cancer DOID:11054 prognostic blood UBERON:0000178 UPKB:P62952 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:decreased;aspect_type:level Decreased level of protein BLCAP/UPKB:P62952 203459 BB1493-1 decreased levels of BLCAP Apoptosis inducing factor BLCAP UPKB:P62952 protein urinary bladder cancer DOID:11054 prognostic blood UBERON:0000178 PubMed:19783793 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:decreased;aspect_type:level Decreased level of protein BLCAP/UPKB:P62952 203459 BB1494-1 loss of function of DDHD1 DDHD1 NCBI:80821 gene hereditary spastic paraplegia DOID:2476 diagnostic blood UBERON:0000178 UPKB:Q8NEL9 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen loss of function of DDHD1 [biomarker_term_in_review] 203460 not_mapped BB1494-1 loss of function of DDHD1 DDHD1 NCBI:80821 gene hereditary spastic paraplegia DOID:2476 diagnostic blood UBERON:0000178 PubMed:37189713 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen loss of function of DDHD1 [biomarker_term_in_review] 203460 not_mapped BB1495-1 increased levels of KLK11 Kallikrein-11 UPKB:Q9UBX7 protein prostate cancer DOID:10283 risk blood UBERON:0000178 UPKB:Q9UBX7 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein KLK11/UPKB:Q9UBX7 203461 BB1495-1 increased levels of KLK11 Kallikrein-11 UPKB:Q9UBX7 protein prostate cancer DOID:10283 risk blood UBERON:0000178 PubMed:16467084 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein KLK11/UPKB:Q9UBX7 203461 BB1495-2 increased levels of KLK11 Kallikrein-11 UPKB:Q9UBX7 protein ovarian cancer DOID:2394 risk blood UBERON:0000178 UPKB:Q9UBX7 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein KLK11/UPKB:Q9UBX7 203462 BB1495-2 increased levels of KLK11 Kallikrein-11 UPKB:Q9UBX7 protein ovarian cancer DOID:2394 risk blood UBERON:0000178 PubMed:16467085 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein KLK11/UPKB:Q9UBX7 203462 BB1496-1 increased levels of AGR3 Anterior gradient protein 3 UPKB:Q8TD06 protein ovarian cancer DOID:2394 risk blood UBERON:0000178 UPKB:Q8TD06 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein AGR3/UPKB:Q8TD06 203463 BB1496-1 increased levels of AGR3 Anterior gradient protein 3 UPKB:Q8TD06 protein ovarian cancer DOID:2394 risk blood UBERON:0000178 PubMed:22361111 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein AGR3/UPKB:Q8TD06 203463 BB1497-1 decreased expression of AZU1 AZU1 NCBI:566 gene breast cancer DOID:1612 risk blood UBERON:0000178 UPKB:O95359 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:decreased;aspect_type:expression Decreased expression of gene AZU1/NCBI:566 203464 BB1497-1 decreased expression of AZU1 AZU1 NCBI:566 gene breast cancer DOID:1612 risk blood UBERON:0000178 PubMed:10749935 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:decreased;aspect_type:expression Decreased expression of gene AZU1/NCBI:566 203464 BB1498-1 increased levels of TRAK1 Trafficking kinesin-binding protein 1 UPKB:Q9UPV9 protein stomach cancer DOID:10534 risk blood UBERON:0000178 UPKB:Q9UPV9 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein TRAK1/UPKB:Q9UPV9 203465 BB1498-1 increased levels of TRAK1 Trafficking kinesin-binding protein 1 UPKB:Q9UPV9 protein stomach cancer DOID:10534 risk blood UBERON:0000178 PubMed:18986759 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein TRAK1/UPKB:Q9UPV9 203465 BB1499-1 increased expression of SLC52A3 SLC52A3 NCBI:113278 gene esophageal cancer DOID:5041 prognostic blood UBERON:0000178 UPKB:Q9NQ40 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:expression Increased expression of gene SLC52A3/NCBI:113278 203466 BB1500-1 increased expression of KIAA1522 NHSL3 NCBI:57648 gene lung non-small cell carcinoma DOID:3908 prognostic blood UBERON:0000178 UPKB:Q9P206 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:expression Increased expression of gene NHSL3/NCBI:57648 203467 BB1501-1 increased levels of LEG10 Galectin-10 UPKB:Q05315 protein eosinophilic esophagitis DOID:13922 diagnostic blood UBERON:0000178 UPKB:Q05315 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein CLC/UPKB:Q05315 203468 AN5627-1 POLE P286R mutation POLE NCBI:5426 gene colorectal cancer DOID:9256 risk blood UBERON:0000178 UPKB:Q07864 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:presence of;mod_type:sequence variation Presence of bmkb_I::P286R sequence variation in gene POLE/NCBI:5426 2270 check_entity BB1502-1 oncreased levels of KLK8 Kallikrein-8 UPKB:O60259 protein ovarian cancer DOID:2394 prognostic blood UBERON:0000178 UPKB:O60259 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein KLK8/UPKB:O60259 203469 BB1503-1 variants of osteopontin Osteopontin UPKB:P10451 protein breast cancer DOID:1612 risk blood UBERON:0000178 UPKB:P10451 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen variants of osteopontin [biomarker_term_in_review] 203470 not_mapped BB1504-1 increased levels of VCAM Vascular cell adhesion protein 1 UPKB:P19320 protein graft-versus-host disease DOID:0081267 risk blood UBERON:0000178 UPKB:P19320 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein VCAM1/UPKB:P19320 203471 BB1505-1 increased expression of IMP3 IMP3 NCBI:55272 gene adenocarcinoma DOID:299 risk blood UBERON:0000178 UPKB:O00425 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:expression Increased expression of gene IMP3/NCBI:55272 203472 BB1506-1 PTPN22 R620W mutation PTPN22 NCBI:26191 gene rheumatoid arthritis DOID:7148 risk blood UBERON:0000178 UPKB:Q9Y2R2 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:presence of;mod_type:sequence variation Presence of bmkb_I::R620W sequence variation in gene PTPN22/NCBI:26191 203473 check_entity BB1506-1 PTPN22 R620W mutation PTPN22 NCBI:26191 gene rheumatoid arthritis DOID:7148 risk blood UBERON:0000178 PubMed:22427951 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:presence of;mod_type:sequence variation Presence of bmkb_I::R620W sequence variation in gene PTPN22/NCBI:26191 203473 check_entity BB1507-1 MITF-M inframe deletions LOC107988030 NCBI:107988030 gene melanoma DOID:1909 diagnostic blood UBERON:0000178 PubMed:20163701 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:presence of;mod_type:sequence variation Presence of bmkb_II::mitf-m:inframe:deletions sequence variation in gene LOC107988030/NCBI: 203474 check_entity BB1507-1 MITF-M inframe deletions LOC107988030 NCBI:107988030 gene melanoma DOID:1909 diagnostic blood UBERON:0000178 UPKB:O75030 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:presence of;mod_type:sequence variation Presence of bmkb_II::mitf-m:inframe:deletions sequence variation in gene LOC107988030/NCBI: 203474 check_entity AN6294-1 increased levels of SAA1 Serum amyloid A-1 protein UPKB:P0DJI8 protein lung cancer DOID:1324 risk blood UBERON:0000178 UPKB:P0DJI8 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein SAA1/UPKB:P0DJI8 203475 AN6294-1 increased levels of SAA1 Serum amyloid A-1 protein UPKB:P0DJI8 protein lung cancer DOID:1324 risk blood UBERON:0000178 PubMed:12973732 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein SAA1/UPKB:P0DJI8 203475 BB1509-1 increased IGFBP-1 levels Insulin-like growth factor-binding protein 1 UPKB:P08833 protein colorectal cancer DOID:9256 diagnostic blood UBERON:0000178 UPKB:P08833 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein IGFBP1/UPKB:P08833 203476 BB1510-1 increased expression of FOXC1 FOXC1 NCBI:2296 gene breast cancer DOID:1612 prognostic blood UBERON:0000178 UPKB:Q12948 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:expression Increased expression of gene FOXC1/NCBI:2296 203477 BB1510-1 increased expression of FOXC1 FOXC1 NCBI:2296 gene breast cancer DOID:1612 prognostic blood UBERON:0000178 PubMed:20406990 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:expression Increased expression of gene FOXC1/NCBI:2296 203477 AN6324-1 increased levels of Mucin-1 Mucin-1 UPKB:P15941 protein breast cancer DOID:1612 monitoring blood UBERON:0000178 UPKB:P15941 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein MUC1/UPKB:P15941 203478 AN6324-1 increased levels of Mucin-1 Mucin-1 UPKB:P15941 protein breast cancer DOID:1612 monitoring blood UBERON:0000178 PubMed:20816948 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein MUC1/UPKB:P15941 203478 BB1512-1 increased levels of SLC3A2 Amino acid transporter heavy chain SLC3A2 UPKB:P08195 protein stomach cancer DOID:10534 diagnostic blood UBERON:0000178 UPKB:P08195 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein SLC3A2/UPKB:P08195 203479 BB1512-1 increased levels of SLC3A2 Amino acid transporter heavy chain SLC3A2 UPKB:P08195 protein stomach cancer DOID:10534 diagnostic blood UBERON:0000178 PubMed:23116296 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein SLC3A2/UPKB:P08195 203479 BB1513-1 increased levels of MYBHL Myosin-binding protein H-like UPKB:A2RUH7 protein cardiovascular system disease DOID:1287 diagnostic blood UBERON:0000178 UPKB:A2RUH7 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein MYBPHL/UPKB:A2RUH7 203480 BB1513-1 increased levels of MYBHL Myosin-binding protein H-like UPKB:A2RUH7 protein cardiovascular system disease DOID:1287 diagnostic blood UBERON:0000178 PubMed:31292467 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein MYBPHL/UPKB:A2RUH7 203480 BB1514-1 hypermethylation of TMEM196 TMEM196 NCBI:256130 gene lung cancer DOID:1324 prognostic blood UBERON:0000178 UPKB:Q5HYL7 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;mod_type:methylation Increased methylation of gene TMEM196/NCBI:256130 203481 BB1514-1 hypermethylation of TMEM196 TMEM196 NCBI:256130 gene lung cancer DOID:1324 prognostic blood UBERON:0000178 PubMed:26056045 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;mod_type:methylation Increased methylation of gene TMEM196/NCBI:256130 203481 BB1515-1 increased expression of LY6K Ly6 NCBI:17062 gene lung non-small cell carcinoma DOID:3908 risk blood UBERON:0000178 PubMed:18089789 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:expression Increased expression of gene Ly6/NCBI:17062 203482 BB1515-1 increased expression of LY6K Ly6 NCBI:17062 gene lung non-small cell carcinoma DOID:3908 risk blood UBERON:0000178 UPKB:Q17RY6 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:expression Increased expression of gene Ly6/NCBI:17062 203482 BB1515-2 increased expression of LY6K Ly6 NCBI:17062 gene esophageal cancer DOID:5041 risk blood UBERON:0000178 PubMed:18089789 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:expression Increased expression of gene Ly6/NCBI:17062 203483 BB1515-2 increased expression of LY6K Ly6 NCBI:17062 gene esophageal cancer DOID:5041 risk blood UBERON:0000178 UPKB:Q17RY6 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:expression Increased expression of gene Ly6/NCBI:17062 203483 BB1516-1 increased levels of NICOL NELL2-interacting cell ontogeny regulator 1 UPKB:Q5BLP8 protein chronic kidney disease DOID:784 risk blood UBERON:0000178 UPKB:Q5BLP8 assessed_biomarker_entity_id;assessed_biomarker_entiy;assessed_entity_type;biomarker;condition;specimen change_type:increased;aspect_type:level Increased level of protein NICOL1/UPKB:Q5BLP8 203484